Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00035594
First received: May 3, 2002
Last updated: May 7, 2013
Last verified: May 2013